Thomas Santarius MRCS a, Peter J Kirkpatrick FMedSci a, Dharmendra Ganesan FRCS[SN] a, Hui Ling Chia MMed a, Ibrahim Jalloh MRCS a, Peter Smielewski PhD a, Hugh K Richards PhD a, Hani Marcus MRCS a, Richard A Parker MSc b, Stephen J Price FRCS[SN] a, Ramez W Kirollos FRCS[SN] a, Prof John D Pickard FMedSci a, Peter J Hutchinson FRCS[SN] a The Lancet, Volume 374, Issue 9695, Pages 1067 - 1073, 26 September 2009
Background
Chronic subdural haematoma causes serious morbidity and mortality. It recurs after surgical evacuation in 5—30% of patients. Drains might reduce recurrence but are not used routinely. Our aim was to investigate the effect of drains on recurrence rates and clinical outcomes.
Methods
We did a randomised controlled trial at one UK centre between November, 2004, and November, 2007. 269 patients aged 18 years and older with a chronic subdural haematoma for burr-hole drainage were assessed for eligibility. 108 were randomly assigned by block randomisation to receive a drain inserted into the subdural space and 107 to no drain after evacuation. The primary endpoint was recurrence needing redrainage. The trial was stopped early because of a significant benefit in reduction of recurrence. Analyses were done on an intention-to-treat basis. This study is registered with the International Standard Randomised Controlled Trial Register (ISRCTN 97314294).
Findings
Recurrence occurred in ten of 108 (9·3%) people with a drain, and 26 of 107 (24%) without (p=0·003; 95% CI 0·14—0·70). At 6 months mortality was nine of 105 (8·6%) and 19 of 105 (18·1%), respectively (p=0·042; 95% CI 0·1—0·99). Medical and surgical complications were much the same between the study groups.
Interpretation
Use of a drain after burr-hole drainage of chronic subdural haematoma is safe and associated with reduced recurrence and mortality at 6 months.
Funding
Academy of Medical Sciences, Health Foundation, and NIHR Biomedical Research Centre (Neurosciences Theme).
Weblink here
Background
Chronic subdural haematoma causes serious morbidity and mortality. It recurs after surgical evacuation in 5—30% of patients. Drains might reduce recurrence but are not used routinely. Our aim was to investigate the effect of drains on recurrence rates and clinical outcomes.
Methods
We did a randomised controlled trial at one UK centre between November, 2004, and November, 2007. 269 patients aged 18 years and older with a chronic subdural haematoma for burr-hole drainage were assessed for eligibility. 108 were randomly assigned by block randomisation to receive a drain inserted into the subdural space and 107 to no drain after evacuation. The primary endpoint was recurrence needing redrainage. The trial was stopped early because of a significant benefit in reduction of recurrence. Analyses were done on an intention-to-treat basis. This study is registered with the International Standard Randomised Controlled Trial Register (ISRCTN 97314294).
Findings
Recurrence occurred in ten of 108 (9·3%) people with a drain, and 26 of 107 (24%) without (p=0·003; 95% CI 0·14—0·70). At 6 months mortality was nine of 105 (8·6%) and 19 of 105 (18·1%), respectively (p=0·042; 95% CI 0·1—0·99). Medical and surgical complications were much the same between the study groups.
Interpretation
Use of a drain after burr-hole drainage of chronic subdural haematoma is safe and associated with reduced recurrence and mortality at 6 months.
Funding
Academy of Medical Sciences, Health Foundation, and NIHR Biomedical Research Centre (Neurosciences Theme).
Weblink here